-
18 Ferry Road, London, England,
SW13 9PR, United Kingdom -
+44 78 0777 4440
info@fundholdingltd.com -
Mon - Fri 9.00 - 18.00
18 Ferry Road, London, England,
SW13 9PR, United Kingdom
+44 78 0777 4440
info@fundholdingltd.com
Mon - Fri 9.00 - 18.00
Our team draws on deep industry expertise, clinical insights and cross-asset class investing experience to drive advances in therapeutics, diagnostics and tools to improve the lives of patients with unmet medical needs.
Fund Holdings Limited Life Sciences invests in
biopharmaceutical, specialty pharmaceutical, medical device,
diagnostics and enabling life science technology companies
globally, with a focus on companies that both drive medical
innovation across the value chain and enable that innovation to
improve the lives of patients with unmet medical needs.
The differentiated skillset of Fund Holdings Limited' team
enables it to pursue opportunities created by several longterm
trends in healthcare. In particular, these trends are creating
an increased need for targeted capital and value-added strategic
support of companies around their critical phases of growth,
during which they must prove their clinical and business value.
Since 2015, Fund Holdings Limited has employed a
strategic, analytical approach to identify attractive investment
opportunities and partner with management teams to transform and
improve their businesses. During this time, Fund Holdings Limited has developed global reach, deep expertise and a
proven track record in the life sciences industries across its
Private Equity, Public Equity, Credit, and Ventures business
units
Scaling innovation in Life Science
Fund Holdings Limited Life Sciences provides targeted and value-added support to pursue innovation that improves the lives of patients.
Targeting companies that drive innovation across
the healthcare value chain
Fundamental analysis and bottom-up stock picking.
Bringing breakthrough advances to market that
improve the lives of patients
Multi-year investment horizon.
Enabling efficient use of capital through rigorous diligence, asset selection and value-added support.